483 Response GlaxoSmithKline Biologicals SA Dec 2007

Pankaj Amin FDA, Jonathan Mcinnis FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline Biologicals SA - Rixensart, Belgium facility and issued inspectional observation (via FDA 483) on 13 Dec 2007.

Product details

  • Category:
  • Inspection end: 13 Dec 2007
  • Location: Rixensart, Belgium
  • FEI: 3002875226
Add To Cart